Skip to main content
. 2017 Jan 5;13(3):1223–1227. doi: 10.3892/ol.2017.5573

Figure 3.

Figure 3.

Dopamine receptor D2 inhibitor thioridazine decreases gastric cancer cell survival. The inhibitory effect of thioridazine on AGS cell proliferation was measured using a 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide assay.